InspireMD Inc.
NSPR
Positions held
Your positionsNSPR isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $22.31M | Enterprise value | -$5.08M | Trailing P/E | — | Forward P/E | -0.99 |
| PEG | — | Price / book | 0.71 | Beta | 0.83 | Dividend yield | 0.00% |
| Revenue growth | -0.4% | Earnings growth | — | Gross margin | 18.1% | Operating margin | -8.2% |
| Profit margin | 0.0% | ROE | -2.0% | ROA | -85.8% | Debt / equity | 0.10 |
| Current ratio | 3.80 | Free cash flow | -$23.11M | Analyst recommendation | none | Mean target | $3.33 |
| 52w high | $2.54 | 52w low | $0.46 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $1.8M | $3.4M | $3.1M | $2.5M | $1.8M | — |
| Op margin | -815.6% | -411.4% | -383.7% | -517.3% | -732.2% | — |
| Net income | -$14.3M | -$13.7M | -$11.8M | -$12.7M | -$13.2M | — |
| Gross margin | -43.7% | 20.2% | 37.5% | 34.2% | 17.6% | — |
| Gross profit | -$0.8M | $0.7M | $1.2M | $0.9M | $0.3M | — |
| Operating income | -$14.4M | -$14.0M | -$12.1M | -$13.1M | -$13.0M | — |
- Revenue -48% vs prior quarter ($1.8M vs $3.4M).
- Gross margin -43.7% (was 20.2% prior quarter).
- Operating margin compressed to -815.6%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $9.0M | $7.0M | $6.2M | $5.2M | — |
| Op margin | -552.6% | -478.0% | -340.7% | -361.9% | — |
| Net income | -$48.8M | -$32.0M | -$19.9M | -$18.5M | — |
| Gross margin | 29.5% | 21.5% | 29.1% | 21.6% | — |
| Gross profit | $2.6M | $1.5M | $1.8M | $1.1M | — |
| Operating income | -$49.6M | -$33.5M | -$21.1M | -$18.7M | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-04 · InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-09-03 · InspireMD to Participate in Upcoming H.C. Wainwright 28th Annual Global Investment Conference
2026-08-20 · InspireMD (NSPR) Upgraded to Buy: Here's What You Should Know
2026-08-17 · InspireMD Inc (NSPR) (Q2 2026) Earnings Call Highlights: Navigating Recall Challenges While ...
2026-08-17 · InspireMD, Inc. Q2 2026 Earnings Call Summary
2026-08-17 · InspireMD Reports Second Quarter 2026 Financial Results
2026-08-14 · InspireMD, Inc. (NSPR) Reports Q2 Loss, Beats Revenue Estimates
2026-08-10 · InspireMD to Announce Second Quarter 2026 Financial Results
2026-08-07 · InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-07-24 · InspireMD Receives Nasdaq Minimum Bid Price Warning
Price (daily)
Full chart · RSI · MACD · patterns